Actigraphy Sensors And Polysomnography Devices Market Size, Share, Growth, and Industry Analysis, By Type (Actigraphy Devices, and PSG Devices) By Application (Homecare Settings, Hospitals, Diagnostic Laboratories, and Others), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

ACTIGRAPHY SENSORS AND POLYSOMNOGRAPHY DEVICES MARKET OVERVIEW

The global Actigraphy Sensors And Polysomnography Devices Market is poised for significant growth rising to USD 1.621 billion in 2025, and projected to reach USD 2.602 billion by 2034, with a CAGR of 5.4% from 2025 to 2034.

A vital role is played by actigraphy and PSG devices in the management of sleep disorders. Sleep disorders, ranging from minor disturbances to major sleep problems, are on the rise as a result of altering sleeping patterns and the prevalence of sleep disorders. The management of chronic sleep disorders at an early stage is extremely important to improve a person's health and quality of life. PSG devices and actigraphy sensors are in high demand as an increasing number of patients seek accurate diagnosis and treatment for sleep disorders. Actigraphy is a miniaturized computer method for monitoring human rest and activity. People wear a small actigraph, also called an actimetry sensor, for a week or more to measure their gross motor activity. Sleepiness and insufficient sleep can be determined by actigraphs. On the other hand, polysomnography (PSG) is the gold standard for evaluating sleep disorders because it can objectively measure sleep-time and wake-up-time, as well as sleep architecture. EEGs, electromyograms, and electrooculograms are electrophysiological recordings which help score various stages of sleep based on electroencephalograms (EEGs), electromyograms (EMGs), and electrooculograms. The associated costs of PSG make it an infrequent procedure, however.

There has been a continuous rise in insomnia, stress-related lifestyles, which in turn increases the number of people who have disturbed sleep cycles and are potential patients. Including these devices in diagnostics and treatment plans helps patients achieve better patient outcomes. Apart from all of these, the limited health awareness to public about sleep disorders restrains the actigraphy sensors and polysomnography devices market growth throughout the forecast period.

KEY FINDINGS

COVID-19 IMPACT

Imposition of Lockdown to Hamper Market 

As a result of COVID-19, the actigraphy sensors and polysomnography devices market growth has also been drastically affected. Particularly hard hit had happened in the global manufacturing, tourism, and financial markets. Despite signs of recovery in the previous period, the downward pressure on the world economy has returned. Even though there were a lot of economic problems due to the sudden lockdown imposed by government and the closure of industries,  actigraphy sensors and polysomnography devices had witnessed a growth in it’s market during the pandemic period. It was majorly due to the rise in awareness of pandemic and the usage of the device. The ease of lockdown and restrictions is further expected to foster the market growth.

LATEST TRENDS

Advancements in Technologies to Drive Market Growth

The healthcare industry is undergoing a technological revolution, so companies in the actigraphy sensors and polysomnography devices are integrating advanced technologies into their manufacturing processes. Diagnostic accuracy and reliability are the primary reasons for applying next-generation technologies, such as the Internet of Things (IoT), to improve salient features of actigraphy sensors and PSG devices. For the most accurate and reliable method of analyzing sleep, manufacturers of actigraphy sensors and PSG devices are experimenting with various technologies, such as radar technology.

• According to the American Academy of Sleep Medicine (AASM), over 70 million Americans suffer from chronic sleep disorders, prompting a 45% rise in the integration of IoT-enabled actigraphy devices for continuous monitoring in the past three years.

• As per the World Health Organization (WHO), sleep deprivation impacts 40% of adults globally, leading to a 52% surge in demand for polysomnography devices equipped with AI-assisted scoring systems for improved diagnostic accuracy.

Request a Free sample to learn more about this report

ACTIGRAPHY SENSORS AND POLYSOMNOGRAPHY DEVICES MARKET SEGMENTATION

By Type

The market is classified into actigraphy devices, and PSG devices based on type. The actigraphy devices segment will lead the actigraphy sensors and polysomnography devices market share throughout the forecast period.

By Application

The market is classified into homecare settings, hospitals, diagnostic laboratories, and others on the basis of application. The homecare settings segment will lead the actigraphy sensors and polysomnography devices market share throughout the forecast period.

DRIVING FACTORS

Increase in Diseases like Sleep Disorders to Drive the Market

Patients with sleep disorders, including insufficient sleep syndrome, can use actigraphy to complement self-reported sleep duration and other sleep parameters. As sleep disorders like insomnia, restless leg syndrome, narcolepsy, sleep apnea, and sleepwalking become more prevalent among adults, the market for actigraphy sensors and polysomnography devices will continue to grow. Older adults, women, and people with medical or mental illness are more likely to suffer from sleep disorders.

• According to the Centers for Disease Control and Prevention (CDC), insufficient sleep is linked to chronic conditions affecting 33% of the U.S. adult population, significantly driving the adoption of actigraphy sensors in preventive healthcare programs.

• The National Sleep Foundation reports that 62% of healthcare providers now recommend home-based PSG testing, increasing accessibility and expanding the market for portable polysomnography devices.

Strict Framework for Devices Manufacturing Strategies to Drive the Market

Actigraphy sensors and PSG devices are regulated by governing bodies around the world with strict guidelines and high standards of accreditation to ensure consumers' health and safety. A recent clinical practice guideline published by the American Academy of Sleep Medicine (AASM) describes how actigraphy sensors can be used to monitor sleep. Regulatory requirements, such as licensing requirements and Medical Code of Conduct, are also mandatory for stakeholders in the actigraphy sensors and polysomnography devices market.

RESTRAINING FACTORS

Limited Awareness About Various Diseases to the Public to Restrain the Market

Throughout the forecast period, the limited awareness about sleep disorders and high prices associated with actigraphy sensors are expected to restrain the market for actigraphy sensors and polysomnography devices.

• As reported by the World Health Organization (WHO), more than 48% of low-income countries lack trained technicians for PSG testing, limiting the adoption of advanced sleep diagnostic devices.

• According to the National Institutes of Health (NIH), high equipment costs result in 37% of small healthcare facilities delaying the purchase of actigraphy and PSG devices, especially in rural regions.

• Request a Free sample to learn more about this report

•  

ACTIGRAPHY SENSORS AND POLYSOMNOGRAPHY DEVICES MARKET REGIONAL INSIGHTS

North America to Dominate the Market Owing to the Increasing Customer Pool

Globally, North America dominates the actigraphy sensors and polysomnography devices market. North America accounted for the highest revenue share due to its large customer pool. Due to Covid-19, the demand for these devices has been increasing for geriatric patients with sleep disturbances. In addition, the key manufacturers of the devices are strengthening their supply chain and distribution in the U.S., as availability plays a significant role in product adoption.

Asia Pacific holds the second largest share of the actigraphy sensors and polysomnography devices market. As a result of increased public spending on wellness, Asia-Pacific is expected to experience significant growth opportunities. Actigraphy sensors and polysomnography devices providers are expected to benefit from the untapped potential of emerging markets such as Asia-Pacific. In countries such as South Korea, India, and Japan, such products are expected to witness high demand due to the recognition of diseases like sleep deprivation and insomnia.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage  

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Philips – As per Philips’ corporate disclosures, the company has expanded its sleep diagnostics portfolio in over 100 countries, with a 41% increase in sales of cloud-connected actigraphy systems for clinical and home use between 2022 and 2024.

• Garmin – According to Garmin’s health division data, 55% of its wearable devices sold in 2023 included advanced actigraphy-based sleep tracking features, marking a 29% year-on-year growth in healthcare applications.

List of Top Actigraphy Sensors And Polysomnography Devices Companies

• Philips (Netherlands)
• Garmin (U.S.)
• Fitbit (U.S.)
• ResMed (U.S.)
• Natus Medical (U.S.)
• Nox Medical (U.S.)
• SOMNOmedics (Germany)
• Compumedics (Australia)
• BMC Medical (China)
• Cleveland
• Cidelec (France)
• ActiGraph (U.S.)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.